1 고성규, "한약물의 ADR" 한의병리학회 18 (18): 957-964, 2004
2 우연주, "중국, 일본, 한국, WHO의 한약 자발적부작용보고체계 현황" 대한한방내과학회 35 (35): 111-118, 2014
3 장종순, "백선 복용후 발생한 독성 간손상의 4예" 대한간학회 14 (14): 206-212, 2008
4 유태우, "독성 간손상 관련 한국인의 약물복용 실태와 건강비용 조사대한간학회지 제 13 권 제 1 호 2007 ; 34-43; 독성 간손상의 진단 및 보고체계 구축을 위한 다기관 공동연구" 대한간학회 13 (13): 34-43, 2007
5 서정철, "급성 독성 간염 48예의 임상 경험" 대한간학회 12 (12): 74-81, 2006
6 김진현, "건강보험의 보장성과 한방의료 급여확대방안" 대한예방한의학회 11 (11): 139-151, 2007
7 Korean Institute for Health and Social Affairs, "Usage and Consumption of Korean Medicine and Perception in Korea"
8 Ministry of Health and Welfares, "Usage and Consumption of Korean Medicine"
9 Ministry of Health and Welfares, "Usage and Consumption of Korean Medicine"
10 U.S. Department Of Health and Human Services, "Traditional Chinese Medicine: An Introduction"
1 고성규, "한약물의 ADR" 한의병리학회 18 (18): 957-964, 2004
2 우연주, "중국, 일본, 한국, WHO의 한약 자발적부작용보고체계 현황" 대한한방내과학회 35 (35): 111-118, 2014
3 장종순, "백선 복용후 발생한 독성 간손상의 4예" 대한간학회 14 (14): 206-212, 2008
4 유태우, "독성 간손상 관련 한국인의 약물복용 실태와 건강비용 조사대한간학회지 제 13 권 제 1 호 2007 ; 34-43; 독성 간손상의 진단 및 보고체계 구축을 위한 다기관 공동연구" 대한간학회 13 (13): 34-43, 2007
5 서정철, "급성 독성 간염 48예의 임상 경험" 대한간학회 12 (12): 74-81, 2006
6 김진현, "건강보험의 보장성과 한방의료 급여확대방안" 대한예방한의학회 11 (11): 139-151, 2007
7 Korean Institute for Health and Social Affairs, "Usage and Consumption of Korean Medicine and Perception in Korea"
8 Ministry of Health and Welfares, "Usage and Consumption of Korean Medicine"
9 Ministry of Health and Welfares, "Usage and Consumption of Korean Medicine"
10 U.S. Department Of Health and Human Services, "Traditional Chinese Medicine: An Introduction"
11 Ernst E, "Toxic heavy metals and undeclared drugs in Asian herbal medicine" 23 (23): 136-139, 2002
12 Choi HJ, "The side effects of using herbal medicine with western medicine" 20 (20): 1-9, 2003
13 Zhu Y, "Specialized Committee for Drung-Induced Liver Disease Chinese Pharmacological Society. Comparison between Chinese herbal medicine and western medicine-induced liver injury of 1985 patients" 2016
14 Wikipedia, "Side effect"
15 Li Z, "Ronald Meyboom, Kelvin Chan, Debbie Shaw, Pierre Duez, Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China : Current status and future perspective" 140 : 519-525, 2012
16 Shin YD, "Research on the present coverage of health insurance of Korean traditional medicine and its activation Plan" Kyung Hee University 2000
17 World Health Organization, "New WHO guidelines to promete proper use of alternative medicines"
18 Zaacks SM, "Hypersensitivity myocarditis associated with ephedra use" 37 (37): 485-489, 1999
19 Rolf T, "Herbal hepatotoxicity in traditional and modern medicine : actual key issue and new encouraging steps" 6 : 72-, 2015
20 Stedman C, "Herbal hepatotoxicity" 22 (22): 195-206, 2002
21 Zhou S, "Herbal bioactivation : The good, the bad and the ugly" 74 : 935-968, 2004
22 McRae CA, "Hepatitis associated with Chinese herbs" 14 : 669-562, 2002
23 Kim NJ, "Expand and development insurance coverage of Korean traditional medicine" Korea Institute of Oriental Medicine 1996
24 Bensoussan A, "Development of a Chinese herbal medicine toxicology database" 40 (40): 159-167, 2002
25 Kessler DA, "Cancer and herbs" 342 : 1742-1743, 2000
26 Park TS, "An introduction to categorical data analysis" Freeaca 1999
27 Greensfelder L., "Alternative medicine. Herbal product linked to cancer" 288 : 1946-, 2000
28 Villegas JF, "Adverse effects of herbal treatment of cardiovascular disease : what the physician must know" 3 (3): 169-175, 2001
29 Haller CA, "Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids" 343 : 1833-1838, 2000